Format

Send to

Choose Destination
See comment in PubMed Commons below
Scand J Gastroenterol. 2001 Jul;36(7):775-9.

Economic burden of NSAID-induced gastropathy in Sweden.

Author information

1
Centre for Health Economics, Stockholm School of Economics, Sweden. hebj@hhs.se

Abstract

BACKGROUND:

Gastrointestinal side effects carry a significant cost related to the use of NSAID medications.

METHODS:

The economic burden of NSAID-induced gastric side effects is estimated using the cost-of-illness methodology. Costs are calculated using both a prevalence (top-down) approach and an incidence (bottom-up) approach.

RESULTS:

Using the top-down approach, the total cost in 1998 of NSAID-induced ulcers was MSEK 329-586, direct costs accounting for 76%-83%. The bottom-up approach gives an estimate of MSEK 320, of which MSEK 290 was direct cost. About one-quarter of total costs for ulcer disease can be attributed to the use of NSAIDs.

CONCLUSIONS:

Gastrointestinal side effects carry a significant cost from the use of NSAIDs, costs that are as important as the price of NSAIDs. This should be considered when choice of drug and prophylaxis is being made.

PMID:
11444479
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center